GYRE: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, GYRE has $162,015K in assets. $25,030K in debts. $37,501K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
463.57%
Quick Ratio
463.57%
Cash Ratio
189.51%
Debt to Asset Ratio
15.45%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Long-term certificates of deposi...
Accounts receivables, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Noncontrolling interest
Others

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Prepaid assets	-	1,338	-	-
Receivable from gcbp-GCBiopharma Corp	-	0	0	0
Inventories, net	-	-	-	8,861
Cash and cash equivalents	37,501	37,070	40,402	36,491
Short-term bank deposits	12,307	15,355	19,647	17,874
Notes receivable	3,817	5,638	693	499
Accounts receivables, net	22,763	31,078	25,877	24,629
Other receivables from gni	230	230	230	230
Inventories	11,352	10,171	8,854	-
Other current assets	-	1,489	-	-
Prepaid assets and other current assets	3,762	-	2,873	2,701
Total current assets	91,732	102,369	98,576	91,285
Property and equipment, gross	31,738	31,175	30,542	-
Less accumulated depreciation	8,166	7,576	6,934	-
Property and equipment, net	23,572	23,599	23,608	23,401
2026	-	694	-	-
2027	-	690	-	-
2028	-	661	-	-
2029	-	659	-	-
2030	-	648	-	-
Gross carrying amount	5,843	-	5,687	-
Thereafter	-	1,375	-	-
Accumulated amortization	1,216	-	840	-
Intangible assets, net	4,627	4,727	4,847	4,962
Right-of-use assets	-	1,131	-	-
Land use rights, net	-	1,425	-	-
Deferred tax assets	7,723	6,873	6,714	6,134
Long-term certificates of deposit	29,419	23,516	20,317	21,528
Other assets, noncurrent	4,942	2,492	5,322	5,336
Total assets	162,015	166,132	159,384	152,646

Accounts payable	265	124	556	71
Contract liabilities	-	14	58	0
Due to related parties	226	227	228	219
Accrued expenses and other current liabilities	15,415	14,345	11,799	14,924
Income tax payable	3,131	2,940	2,646	1,084
Operating lease liabilities, current	751	636	626	622
Cvr derivative liability	-	-	0	0
Total current liabilities	19,788	18,286	15,913	16,920
Operating lease liabilities, noncurrent	72	303	539	771
Deferred government grants	840	852	866	884
Warrant liability, noncurrent	2,872	2,961	3,224	3,201
Other noncurrent liabilities	1,458	1,448	1,427	1,427
Total liabilities	25,030	23,850	21,969	23,203
Common stock, 0.001 par value, 400,000,000 shares authorized 91,337,121 shares and 91,314,007 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively	91	91	91	91
Additional paid-in capital	174,651	172,047	167,134	161,437
Statutory reserve	3,648	3,098	3,098	3,098
Accumulated deficit	-77,667	-68,426	-66,703	-70,313
Accumulated other comprehensive income (loss)	586	-779	-1,700	-2,287
Total gyre stockholders' equity	101,309	106,031	101,920	92,026
Noncontrolling interest	35,676	36,251	35,495	37,417
Total equity	136,985	142,282	137,415	129,443
Total liabilities and stockholders' equity	162,015	166,132	159,384	152,646

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets